Cita APA

Rasschaert, M., Schrijvers, D., Van den Brande, J., Dyck, J., Bosmans, J., Merkle, K., & Vermorken, J. B. (2007). A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours. Nature Publishing Group.

Citación estilo Chicago

Rasschaert, M., D. Schrijvers, J. Van den Brande, J. Dyck, J. Bosmans, K. Merkle, y J B. Vermorken. A Phase I Study of Bendamustine Hydrochloride Administered Day 1+2 Every 3 Weeks in Patients With Solid Tumours. Nature Publishing Group, 2007.

Cita MLA

Rasschaert, M., et al. A Phase I Study of Bendamustine Hydrochloride Administered Day 1+2 Every 3 Weeks in Patients With Solid Tumours. Nature Publishing Group, 2007.